Phase 1 Dose Escalation Study of LY2090314 in Patients With Advanced or Metastatic Cancer in Combination With Pemetrexed and Carboplatin
Phase of Trial: Phase I
Latest Information Update: 20 Jun 2011
At a glance
- Drugs Carboplatin; LY 2090314; Pemetrexed
- Indications Cancer
- Focus Adverse reactions
- 20 Jun 2011 Actual end date (Apr 2011) added as reported by ClinicalTrials.gov.
- 20 Jun 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 09 Apr 2011 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.